Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:307579rdf:typepubmed:Citationlld:pubmed
pubmed-article:307579lifeskim:mentionsumls-concept:C0079772lld:lifeskim
pubmed-article:307579lifeskim:mentionsumls-concept:C1521970lld:lifeskim
pubmed-article:307579lifeskim:mentionsumls-concept:C0549178lld:lifeskim
pubmed-article:307579lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:307579lifeskim:mentionsumls-concept:C1553412lld:lifeskim
pubmed-article:307579lifeskim:mentionsumls-concept:C1548328lld:lifeskim
pubmed-article:307579pubmed:issue1lld:pubmed
pubmed-article:307579pubmed:dateCreated1978-9-25lld:pubmed
pubmed-article:307579pubmed:abstractTextTransplanted lymphomas (Thy 1.2+, Ig-) of BALB/c mice, induced by the injection of 1-ethyl-1-nitrosourea, were adapted for growth as in vitro lines to provide potential tools for investigation of T lymphocyte differentiation and functions. All these tissue culture lines maintained the same pattern of surface differentiation antigens (Ly, TL, and Thy-1 antigens) as they had expressed during in vivo passages: BALENTL 13 was Thy 1.2+, TL.2-, and Ly 1+2-. BALENTL 3, 4, 5, 6, 7, 8, and 14 were Thy 1.2+, TL.2+, and Ly 1-2+. P1798 and BALENTL 9 were Thy 1.2+, TL.2+, and Ly 1-2+. There were various levels of terminal transferase activity present among these T cell tumor lines. The range of variation was from 4.6 units/10(8) cells to 29.3 units/10(8) cells (normal thymocytes, 5.0 units/10(8) cells). This 6-fold variation in TdT activity was present even among those cell lines which were Ly 1-2+, TL+. Most cultures lines had chromosome numbers near 40 and generation times of 11 to 22 hr. There were no significant morphologic changes after the adaptation of these tumors in culture except an increase in cytoplasmic C-type virus particles.lld:pubmed
pubmed-article:307579pubmed:languageenglld:pubmed
pubmed-article:307579pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:307579pubmed:citationSubsetAIMlld:pubmed
pubmed-article:307579pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:307579pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:307579pubmed:statusMEDLINElld:pubmed
pubmed-article:307579pubmed:monthJullld:pubmed
pubmed-article:307579pubmed:issn0022-1767lld:pubmed
pubmed-article:307579pubmed:authorpubmed-author:AsofskyRRlld:pubmed
pubmed-article:307579pubmed:authorpubmed-author:HamL BLBlld:pubmed
pubmed-article:307579pubmed:authorpubmed-author:MathiesonB...lld:pubmed
pubmed-article:307579pubmed:authorpubmed-author:McKeeverP EPElld:pubmed
pubmed-article:307579pubmed:authorpubmed-author:WeinbaumF IFIlld:pubmed
pubmed-article:307579pubmed:issnTypePrintlld:pubmed
pubmed-article:307579pubmed:volume121lld:pubmed
pubmed-article:307579pubmed:ownerNLMlld:pubmed
pubmed-article:307579pubmed:authorsCompleteYlld:pubmed
pubmed-article:307579pubmed:pagination339-44lld:pubmed
pubmed-article:307579pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-A...lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-M...lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-C...lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-A...lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-C...lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-L...lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-N...lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-C...lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-K...lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-C...lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-M...lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-T...lld:pubmed
pubmed-article:307579pubmed:meshHeadingpubmed-meshheading:307579-E...lld:pubmed
pubmed-article:307579pubmed:year1978lld:pubmed
pubmed-article:307579pubmed:articleTitleCharacteristics of BALB/C T cell lymphomas grown as continuous in vitro lines.lld:pubmed
pubmed-article:307579pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:307579lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:307579lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:307579lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:307579lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:307579lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:307579lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:307579lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:307579lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:307579lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:307579lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:307579lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:307579lld:pubmed